Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

931
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
931
Erythropoiesis01:14

Erythropoiesis

4.2K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

449
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
449
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

5.7K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
5.7K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

2.0K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Utility of Body Weight Monitoring During Cisplatin-based Chemotherapy.

In vivo (Athens, Greece)·2026
Same author

Effects of imeglimin on experimental diabetic neuropathy in streptozotocin-induced diabetic rats.

Journal of diabetes investigation·2026
Same author

Imeglimin improves hyperglycemia and hypoglycemia-induced cell death and mitochondrial dysfunction in immortalized adult mouse Schwann IMS32 cells.

Journal of diabetes investigation·2025
Same author

[Neurodegeneration Associated with Metal Metabolism].

Brain and nerve = Shinkei kenkyu no shinpo·2025
Same author

Photoinduced Actin Aggregation Involves Cell Death: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy.

ACS nano·2025
Same author

Role of Exogenous Pyruvate in Maintaining Adenosine Triphosphate Production under High-Glucose Conditions through PARP-Dependent Glycolysis and PARP-Independent Tricarboxylic Acid Cycle.

International journal of molecular sciences·2024

Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

474

A Revised Classification of Primary Iron Overload Syndromes.

Yasuaki Tatsumi1, Motoyoshi Yano2, Shinya Wakusawa3

  • 1Department of Medical Biochemistry, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.

Journal of Clinical and Translational Hepatology
|April 19, 2024
PubMed
Summary

This study renews the classification of primary iron overload syndromes (PIOSs) by incorporating new findings on hepcidin25 (Hep25) and ferroportin (FP). The updated PIOS classification aids in diagnosing and treating iron overload disorders globally.

Keywords:
EthnicityFerroportinHemochromatosisHepcidin25Iron overload syndrome

More Related Videos

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.1K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K

Related Experiment Videos

Last Updated: Jun 28, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

474
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.1K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Hematology

Background:

  • Hepcidin25 (Hep25) and ferroportin (FP) are key regulators in iron metabolism.
  • Primary iron overload syndromes (PIOSs) were previously classified in 2012 based on the Hep25/FP system.
  • Accumulated evidence necessitates a renewal of the PIOS classification.

Purpose of the Study:

  • To renew the classification of primary iron overload syndromes (PIOSs).
  • To integrate new molecular discoveries into the PIOS framework.
  • To provide an updated diagnostic and therapeutic guideline for PIOSs.

Main Methods:

  • Retrospective review of the 2012 PIOS classification.
  • Integration of new data on hepcidin25 (Hep25), ferroportin (FP), and erythroferrone.
  • Analysis of molecular mechanisms underlying different PIOS subtypes.

Main Results:

  • Iron-loading anemia included as a prehepatic PIOS due to erythroferrone-induced Hep25 suppression.
  • Traditional FP disease (FP-D) remodeled as the BIOIRON proposal.
  • Hepatic PIOSs encompass four HC genotypes with reduced Hep25 synthesis; posthepatic PIOSs involve mutant FP resistance to Hep25.

Conclusions:

  • The revised PIOS classification incorporates novel molecular insights.
  • Updated classification aids in understanding and managing diverse iron overload conditions.
  • The renewed classification is proposed for worldwide clinical utility.